SCHEMBL3063140

SCHEMBL3063140

CCCCCCC(C)Nc1cccc2cccnc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.61
HSP90AA1 P07900 6/20 0.53
HSP90AB1 P08238 6/20 0.53
CYP1A2 P05177 3/20 0.51
KDM4E B2RXH2 2/20 0.51
CASP1 P29466 2/20 0.51
ALDH1A1 P00352 2/20 0.51
LMNA P02545 2/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C19 P33261 2/20 0.51
TP53 P04637 2/20 0.51
ABCB11 O95342 1/20 0.51
ESR1 P03372 1/20 0.51
PGR P06401 1/20 0.51
ADRB2 P07550 1/20 0.51
CHRM2 P08172 1/20 0.51
ADRB1 P08588 1/20 0.51
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1382276 0.85 HSP90AA1 (0.71) IDO1HSP90AA1HSP90AB1CYP1A2KDM4E
SCHEMBL13064134 0.80 IDO1 (0.93) IDO1HSP90AA1HSP90AB1CYP1A2KDM4E
SCHEMBL3072942 0.80 TRPV1 (0.46) IDO1ALDH1A1LMNACYP2D6CYP2C19
SCHEMBL11527742 0.77 ADH1B (0.44) IDO1KDM4EALDH1A1ADRB2NPSR1
SCHEMBL10597073 0.77 ADH1B (0.44) IDO1KDM4EALDH1A1ADRB2NPSR1
SCHEMBL11526271 0.77 ADH1B (0.44) IDO1KDM4EALDH1A1ADRB2NPSR1
SCHEMBL11584047 0.77 HSP90AA1 (0.52) HSP90AA1HSP90AB1KDM4EALDH1A1HTR1A
SCHEMBL6038007 0.77 HSP90AA1 (0.52) HSP90AA1HSP90AB1KDM4EALDH1A1HTR1A
SCHEMBL28963638 0.77 KDM4E (0.57) IDO1KDM4ELMNAHPGD
SCHEMBL28963762 0.77 KDM4E (0.57) IDO1KDM4ELMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399447-B2 Metal triangulo compound and methods of using the same NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-03-19 US disclosed
US-20100209431-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME NATIONAL UNIVERSITY OF SINGAPORE 2010-08-19 US disclosed
EP-2147005-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME National University of Singapore (SG) 2010-01-27 EP disclosed
WO-2008127197-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME NATIONAL UNIVERSITY OF SINGAPORE (SG) 2008-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100209431-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME CASP3, BAX, CASP7 IDO1 3883/4885HSP90AA1 3253/4885HSP90AB1 3213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.